Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer

Loss of PIK3R1 in ovarian cancer is a common event, which provides opportunities for therapeutic intervention. Here, the authors show that the STAT3 and AKT signaling pathways are activated upon PIK3R1 loss and that, in mice, inhibitors of these pathways could block tumorigenesis.

Bibliographic Details
Main Authors: Xinran Li, Victor C. Y. Mak, Yuan Zhou, Chao Wang, Esther S. Y. Wong, Rakesh Sharma, Yiling Lu, Annie N. Y. Cheung, Gordon B. Mills, Lydia W. T. Cheung
Format: Article
Language:English
Published: Nature Publishing Group 2019-02-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-019-08574-7
id doaj-85e4150d1ad2485d83cd05457232c1ef
record_format Article
spelling doaj-85e4150d1ad2485d83cd05457232c1ef2021-05-11T11:44:10ZengNature Publishing GroupNature Communications2041-17232019-02-0110111610.1038/s41467-019-08574-7Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancerXinran Li0Victor C. Y. Mak1Yuan Zhou2Chao Wang3Esther S. Y. Wong4Rakesh Sharma5Yiling Lu6Annie N. Y. Cheung7Gordon B. Mills8Lydia W. T. Cheung9School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong KongSchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong KongSchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong KongDepartment of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan UniversityDepartment of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong KongProteomics & Metabolomics Core Facility, Li Ka Shing Faculty of Medicine, The University of Hong KongDepartment of Systems Biology, University of Texas MD Anderson Cancer CenterDepartment of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong KongKnight Cancer Institute, Oregon Health & Science UniversitySchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong KongLoss of PIK3R1 in ovarian cancer is a common event, which provides opportunities for therapeutic intervention. Here, the authors show that the STAT3 and AKT signaling pathways are activated upon PIK3R1 loss and that, in mice, inhibitors of these pathways could block tumorigenesis.https://doi.org/10.1038/s41467-019-08574-7
collection DOAJ
language English
format Article
sources DOAJ
author Xinran Li
Victor C. Y. Mak
Yuan Zhou
Chao Wang
Esther S. Y. Wong
Rakesh Sharma
Yiling Lu
Annie N. Y. Cheung
Gordon B. Mills
Lydia W. T. Cheung
spellingShingle Xinran Li
Victor C. Y. Mak
Yuan Zhou
Chao Wang
Esther S. Y. Wong
Rakesh Sharma
Yiling Lu
Annie N. Y. Cheung
Gordon B. Mills
Lydia W. T. Cheung
Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer
Nature Communications
author_facet Xinran Li
Victor C. Y. Mak
Yuan Zhou
Chao Wang
Esther S. Y. Wong
Rakesh Sharma
Yiling Lu
Annie N. Y. Cheung
Gordon B. Mills
Lydia W. T. Cheung
author_sort Xinran Li
title Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer
title_short Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer
title_full Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer
title_fullStr Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer
title_full_unstemmed Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer
title_sort deregulated gab2 phosphorylation mediates aberrant akt and stat3 signaling upon pik3r1 loss in ovarian cancer
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2019-02-01
description Loss of PIK3R1 in ovarian cancer is a common event, which provides opportunities for therapeutic intervention. Here, the authors show that the STAT3 and AKT signaling pathways are activated upon PIK3R1 loss and that, in mice, inhibitors of these pathways could block tumorigenesis.
url https://doi.org/10.1038/s41467-019-08574-7
work_keys_str_mv AT xinranli deregulatedgab2phosphorylationmediatesaberrantaktandstat3signalinguponpik3r1lossinovariancancer
AT victorcymak deregulatedgab2phosphorylationmediatesaberrantaktandstat3signalinguponpik3r1lossinovariancancer
AT yuanzhou deregulatedgab2phosphorylationmediatesaberrantaktandstat3signalinguponpik3r1lossinovariancancer
AT chaowang deregulatedgab2phosphorylationmediatesaberrantaktandstat3signalinguponpik3r1lossinovariancancer
AT esthersywong deregulatedgab2phosphorylationmediatesaberrantaktandstat3signalinguponpik3r1lossinovariancancer
AT rakeshsharma deregulatedgab2phosphorylationmediatesaberrantaktandstat3signalinguponpik3r1lossinovariancancer
AT yilinglu deregulatedgab2phosphorylationmediatesaberrantaktandstat3signalinguponpik3r1lossinovariancancer
AT annienycheung deregulatedgab2phosphorylationmediatesaberrantaktandstat3signalinguponpik3r1lossinovariancancer
AT gordonbmills deregulatedgab2phosphorylationmediatesaberrantaktandstat3signalinguponpik3r1lossinovariancancer
AT lydiawtcheung deregulatedgab2phosphorylationmediatesaberrantaktandstat3signalinguponpik3r1lossinovariancancer
_version_ 1721446084545347584